DESCRIPTION (from abstract): There are 3.5 million Americans with low
vision, most of whom have reading difficulty. Macular degeneration is the
leading cause, and often results in a loss of central vision. The reading
deficits of people with central-field loss is a major, unsolved health
problem, and is the primary focus of this proposal. Dr. Legge and his
colleagues have developed an ideal-observer model of reading that provides a
theoretical basis for understanding how central-field loss affects reading.
The concept of the visual span plays a key role in the model. The visual
span is the number of letters that are identified in a single glance during
reading. The normal visual span is limited to about 10 letters in width.
This small visual span is further diminished or distorted as a consequence
of eye disease. The main hypothesis underlying this proposal is that the
properties of the visual span can account for much (and perhaps all) of the
unexplained reading deficits from central-field loss. In four series of
experiments, Dr. Legge proposes to test specific hypotheses that account for
reading deficits in terms of (i) spatiotemporal properties of letter
recognition across the visual span; (ii) letter interactions within the
visual span; (iii) global properties of the visual span (shape and size);
and (iv) the influence of linguistic and motor constraints. The research
plan also includes development of two new clinical tests, one for assessing
contrast deficits in reading, and the other for measuring Braille reading
speed.
No Sub Projects information available for 5R01EY002934-22
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EY002934-22
Patents
No Patents information available for 5R01EY002934-22
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EY002934-22
Clinical Studies
No Clinical Studies information available for 5R01EY002934-22
News and More
Related News Releases
No news release information available for 5R01EY002934-22
History
No Historical information available for 5R01EY002934-22
Similar Projects
No Similar Projects information available for 5R01EY002934-22